Eli Lilly sues companies selling compounded versions of Zepbound and Mounjaro

The pharmaceutical giant argues the companies arent following compounding rules By Mark Huffman of ConsumerAffairs April…

Eli Lilly reports successful Phase 3 trial for its new diabetes pill

If approved, the pill would compete with injectable GLP-1 drugs By Mark Huffman of ConsumerAffairs April…